| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |